中国人群稳定性缺血性心脏病风险管理公众指南

标题: 中国人群稳定性缺血性心脏病风险管理公众指南
title: Chinese Public Guideline for the Management of Stable Ischemic Heart Disease
版本: 原创版
version: Original
分类: 标准指南
classification: Standard guideline
领域: 预防
field: Prevention
国家和地区: 中国
Country and region: China
指南使用者: 全国各地、各民族的健康人群和心血管病高风险人群。
Guide users: Healthy people and people at high risk for cognitive decline and dementia in all regions of China
证据分级方法: 对稳定性缺血性心脏病证据体采用GRADE方法进行质量评价。根据GRADE方法,将证据质量分为高、中、低、极低四个等级。在证据分级过程中,存在五个降级因素:局限性、不精确性、不一致性、不直接性以及发表偏倚和三个升级因素:效应量大、剂量反应关系以及可能的混杂因素(负偏倚)。
Evidence grading method: The GRADE method was used to evaluate the quality of evidence related to cognitive decline and dementia. According to the GRADE method, the quality of evidence is divided into high quality, moderate quality, low quality, and very low quality. In the evidence grading process, there are five downgrading factors: limitations, imprecision, inconsistency, indirectness, and publication bias, and three upgrading factors: large effect size, dose-response relationship and possible confounders (negative bias).
制定单位: 中国人群健康风险管理协作组-心血管病专业组
Formulating unit: Chinese Health Rlsk MAnagement Collaboration (CHRIMAC)
注册时间: 2023-12-11
Registration time:
注册编号: PREPARE-2023CN178
Registration number:
指南制订的目的: 近年来,随着我国生活方式的变迁和社会发展,缺血性心脏病在中国呈逐年上升的趋势,成为主要的健康挑战之一。本指南旨在根据最新的流行病学数据,通过倡导健康生活方式、明智饮食选择、适量运动等措施,为公众提供实用的、个性化的健康建议,以降低缺血性心脏病的发病风险,促进公众心血管健康。
Purpose of the guideline: Stable ischemic heart disease has emerged as a significant health burden in China, with a consistent rise in recent years attributed to lifestyle changes and social developments. The guidelines aimed to mitigate the risk of ischemic heart disease and enhance cardiovascular health in the public by providing practical and personalized health recommendations, such as advocating for healthy lifestyles, making wise dietary choices, and encouraging moderate exercise, through the latest epidemiological evidence.